台股 » 個股 » 共信-KY » 籌碼相關 » 券商分點績效 » 券商分點個股進出

共信-KY

(6617)
  • 股價
    117.0
  • 漲跌
    ▼0.5
  • 漲幅
    -0.43%
  • 成交量
    97
  • 產業
    上櫃 生技醫療類股
  • 42人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
共信-KY (6617)籌碼相關-元大-屏南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-屏南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/09/271117.5000.00117.0013520.28%
2024/09/2300.000120.67120.5003750.00%
2024/09/200122.5000.00121.0003900.00%
2024/09/1600.001122.50121.00-1475-0.21%
2024/09/121124.5000.00124.5015240.19%
2024/09/1100.002121.00128.00-2566-0.35%
2024/09/101123.5000.00120.0015630.18%
2024/09/061127.501126.50126.0005610.00%
2024/09/051129.0000.00126.0015590.18%
2024/08/2700.001125.50127.50-1557-0.18%
2024/08/261125.001124.00125.5005550.00%
2024/08/231127.0200.00126.0015520.18%
2024/08/2200.001121.00129.00-1543-0.18%
2024/08/211113.5000.00121.5015280.19%
2024/08/1400.00197.1096.50-1499-0.20%
2024/08/131101.5000.00101.0014910.20%
2024/08/1200.001103.50101.50-1492-0.20%
2024/08/091102.0000.00102.0014900.20%
2024/08/0800.001104.00102.50-1487-0.21%
2024/08/071108.501106.00108.5004840.00%
2024/08/061102.5000.00103.5014710.21%
2024/08/0200.004126.38124.00-4461-0.87%
2024/07/2300.001138.50140.50-1445-0.22%
2024/07/221140.501143.00138.5004420.00%
2024/07/191142.5000.00142.0014370.23%
2024/07/1800.001140.50141.00-1427-0.23%
2024/07/171135.5000.00136.0014180.24%
2024/07/0500.001139.00139.50-1404-0.25%
2024/07/041144.501140.00140.0004020.00%
2024/07/0300.001135.50143.00-1393-0.25%
2024/07/021138.002138.50137.50-1383-0.26%
2024/07/011142.501144.50142.5003780.00%
2024/06/281147.501147.50147.0003730.00%
2024/06/274150.500.1150.03147.003.93691.05%
2024/06/261153.017153.21153.00-6357-1.68%
2024/06/255145.802149.00147.5033420.88%
2024/06/244151.502152.50147.0023290.61%
2024/06/211158.003.9156.62160.00-2.9300-0.95%
2024/06/202140.751141.50146.5012530.39%
2024/06/1900.007133.00128.50-7214-3.26%
2024/06/181.2133.3800.00132.001.21990.60%
〈熱門股〉共信-KY旗下PTS進軍寵物市場 跌深反彈周漲逾2成Anue鉅亨-2024/08/24
共信-KY動物抗癌新藥申請台灣藥證 明年H2有望取得藥證Anue鉅亨-2024/07/31
共信-KY 相關文章
共信-KY 相關影音